Veracyte operates as a diagnostics company offering tests for various cancers, including thyroid, prostate, breast, lung, and lymphoma. Products include Afirma, Decipher, Prosigna, Percepta, and Envisia. The company also develops the nCounter analysis system and LymphMark test.
| Indicator | Value |
|---|---|
| PER | 88.2 |
| EV/EBITDA | 35.5 |
| Price/Free Cash Flow' | 33.4 |
| ROIC | 6.1% |
| Net Debt/EBITDA | 100.0 |